Coeliac disease (Q28242747)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Coeliac disease (English)

2 references

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Gino R Corazza

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Antonio Di Sabatino

series ordinal

1

1 reference

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

Gino Roberto Corazza

series ordinal

2

1 reference

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

2 references

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

373

2 references

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

9673

2 references

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1480-1493

2 references

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

A History of Coeliac Disease

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Prevalence of Celiac disease among children in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Mass screening for coeliac disease using antihuman transglutaminase antibody assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Seroprevalence, correlates, and characteristics of undetected coeliac disease in England

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

A prospective study of the incidence of childhood celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Why is coeliac disease endemic in the people of the Sahara?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Chemistry of gluten proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Celiac disease: pathogenesis of a model immunogenetic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Wheat peptide challenge in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The precipitating factor in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Structural basis for gluten intolerance in celiac sprue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Concordance, disease progression, and heritability of coeliac disease in Italian twins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Celiac disease genetics: current concepts and practical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Genetic background of celiac disease and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Genome search in celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Candidate gene region 2q33 in European families with coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Newly identified genetic risk variants for celiac disease related to the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Breast-feeding protects against celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Identification of tissue transglutaminase as the autoantigen of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Antigen Presentation to Celiac Lesion-Derived T Cells of a 33-Mer Gliadin Peptide Naturally Formed by Gastrointestinal Digestion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Matrix metalloproteinase pattern in celiac duodenal mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Interferon-alpha drives T cell-mediated immunopathology in the intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Inhibition of TGF-β Signaling by IL-15: A New Role for IL-15 in the Loss of Immune Homeostasis in Celiac Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Characteristics of adult celiac disease in the USA: results of a national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Coeliac disease detected by screening is not silent--simply unrecognized

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Bone mass and metabolism in patients with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Osteoporosis in adult patients with celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Coeliac disease and the risk of fractures - a general population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Should patients with coeliac disease have their bone mineral density measured?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The liver in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Neurologic presentation of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Coeliac disease and reproductive disorders: a neglected association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Normal small bowel biopsy followed by coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Follow-up study of coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Coeliac disease in primary care: case finding study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Case-finding in coeliac disease should be intensified

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

How many duodenal biopsy specimens are required to make a diagnosis of celiac disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Duodenal bulb biopsies in celiac disease: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The histopathology of coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Clinical features and diagnosis of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Uselessness of anti-actin antibody in celiac disease screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Scalloped valvulae conniventes: an endoscopic marker of celiac sprue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Reevaluation of duodenal endoscopic markers in the diagnosis of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

All that scallops is not celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Tailored testing for celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The teenage coeliac: follow up study of 102 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Celiac disease and the transition from childhood to adulthood: a 28-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Celiac diet: Its impact on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Reliability of immunologic markers of celiac sprue in the assessment of mucosal recovery after gluten withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Follow-up of patients with celiac disease: achieving compliance with treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

No observed local immunological response at cell level after five years of oats in adult coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Oats induced villous atrophy in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The molecular basis for oat intolerance in patients with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Mortality in patients with coeliac disease and their relatives: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Causes of death in patients with celiac disease in a population-based Swedish cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Malignancy and mortality in people with coeliac disease: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Long-Term Mortality in People With Celiac Disease Diagnosed in Childhood Compared With Adulthood: A Population-Based Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Abnormal intestinal intraepithelial lymphocytes in refractory sprue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Autoimmune enteropathy and villous atrophy in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Clinical staging and survival in refractory celiac disease: a single center experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Cladribine therapy in refractory celiac disease with aberrant T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

A reassessment of splenic hypofunction in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Impairment of splenic IgM-memory but not switched-memory B cells in a patient with celiac disease and splenic atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Pneumococcal infection in patients with coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Coeliac disease and risk of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Characterization of cereal toxicity for celiac disease patients based on protein homology in grains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Natural Variation in Toxicity of Wheat: Potential for Selection of Nontoxic Varieties for Celiac Disease Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

A non-human primate model for gluten sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960254-3

7 January 2021

10.1016/S0140-6736(09)60254-3

Identifiers

DOI

3 references

https://doi.org/10.1016%2FS0140-6736%2809%2960254-3

9 April 2017

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19394538%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017